Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia.

Madamsetty, Vijay Sagar; Paulus, Aneel; Akhtar, Sharoon; Manna, Alak; Rachamalla, Harikrishna Reddy; Banerjee, RajKumar; Mukhopadhyay, Debabrata; Chanan-Khan, Asher

Madamsetty, Vijay Sagar; Paulus, Aneel; Akhtar, Sharoon; Manna, Alak; Rachamalla, Harikrishna Reddy; Banerjee, RajKumar; Mukhopadhyay, Debabrata; Chanan-Khan, Asher.

Affiliation

Madamsetty VS; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.
Paulus A; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Akhtar S; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Manna A; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Rachamalla HR; Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.
Banerjee R; Academy of Scientific and Innovative Research (AcSIR, CSIR - Human Resource Development Centre, (CSIR-HRDC) Campus, Ghaziabad, India.
Mukhopadhyay D; Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.
Chanan-Khan A; Academy of Scientific and Innovative Research (AcSIR, CSIR - Human Resource Development Centre, (CSIR-HRDC) Campus, Ghaziabad, India.

Leuk Lymphoma ; 61(10): 2399-2408, 2020 10.

Article in En | MEDLINE | ID: mdl-32558607

Subject(s)
Key words

Waldenstrom macroglobulinemia; bortezomib; nanoparticles

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Waldenstrom Macroglobulinemia / Proteasome Inhibitors Limits: Animals Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google